201 related articles for article (PubMed ID: 24014103)
1. FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.
Zhong-Xing Z; Yuan-Yuan M; Hai Zhen M; Jian-Gang Z; Li-Feng Z
PLoS One; 2013; 8(8):e73700. PubMed ID: 24014103
[TBL] [Abstract][Full Text] [Related]
2. Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.
Wang X; Xing GH; Fan CC
DNA Cell Biol; 2014 May; 33(5):320-7. PubMed ID: 24568648
[TBL] [Abstract][Full Text] [Related]
3. Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.
Liu T; Zuo L; Li L; Yin L; Liang K; Yu H; Ren H; Zhou W; Jing H; Liu Y; Kong C
Tumour Biol; 2014 Nov; 35(11):10911-8. PubMed ID: 25085585
[TBL] [Abstract][Full Text] [Related]
4. Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.
Li K; Li W; Zou H; Zhao L
Tumour Biol; 2014 Jan; 35(1):351-6. PubMed ID: 23979975
[TBL] [Abstract][Full Text] [Related]
5. Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.
Wang GQ; Bao L; Zhao XX; Zhang J; Nan KJ
Tumour Biol; 2014 May; 35(5):4107-12. PubMed ID: 24375196
[TBL] [Abstract][Full Text] [Related]
6. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
8. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
[TBL] [Abstract][Full Text] [Related]
10. Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.
Chen Y; Wang H; Yan Y; Ren M; Yan C; Wang B
Medicine (Baltimore); 2019 Dec; 98(49):e18240. PubMed ID: 31804351
[TBL] [Abstract][Full Text] [Related]
11. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.
Huang D; Xiao J; Deng X; Ma K; Liang H; Shi D; Wu F; Shao Z
BMC Musculoskelet Disord; 2018 May; 19(1):137. PubMed ID: 29734947
[TBL] [Abstract][Full Text] [Related]
12. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
[TBL] [Abstract][Full Text] [Related]
13. Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.
Rehman S; Saba N; Naz M; Ahmed P; Munir S; Sajjad S; Tabassum S; Naseem L
Immunol Invest; 2018 Jul; 47(5):484-491. PubMed ID: 29611722
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
Daripally S; Nallapalle SR; Katta S; Prasad VV
Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
[TBL] [Abstract][Full Text] [Related]
15. Fas -670A/G (rs1800682) polymorphism and digestive cancer risk in Asians: a meta-analysis.
Yuan HP; Liu QD; Li GQ; Cong YQ
Genet Test Mol Biomarkers; 2014 Jul; 18(7):482-8. PubMed ID: 24800976
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis.
Chen X; Mo W; Peng Q; Su X
BMC Med Genet; 2013 Jul; 14():71. PubMed ID: 23865866
[TBL] [Abstract][Full Text] [Related]
17. The role of FAS gene variants in inflammatory bowel disease.
Demir A; Kahraman R; Candan G; Ergen A
Turk J Gastroenterol; 2020 May; 31(5):356-361. PubMed ID: 32519954
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians.
Karimi MY; Kapoor V; Sharma SC; Das SN
Cancer Invest; 2013 Jan; 31(1):1-6. PubMed ID: 23153021
[TBL] [Abstract][Full Text] [Related]
19. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
Shao P; Ding Q; Qin C; Wang M; Tang J; Zhu J; Chen J; Cao Q; Li J; Xu B; Zhang Z; Zhang W; Yin C
Prostate; 2011 Jul; 71(10):1122-30. PubMed ID: 21557277
[TBL] [Abstract][Full Text] [Related]
20. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
